Ms. Lee is a member of the firms Biotechnology/Pharmaceutical Group. She has extensive experience in prosecuting patent applications and writing opinions regarding patentability, infringement and freedom-to-operate. Ms. Lee’s work focuses on biotechnology area including nucleic acid and polypeptide sequences, antibodies, pharmaceuticals, and regenerative drug areas. Her work also covers drug delivery systems. She was a member of the firm's litigation team for the recent AZ v. Hanmi in the District Court of New Jersey, which was the Korean drug companies' first US Hatch-Waxman litigation.
She is named in the 2015 Rising Stars within the Washington DC metropolitan area by the Washington DC Super Lawyers Magazine. She speaks fluent Korean and is a registered Korean Patent Attorney.
Ms. Lee serves as a co-chair of the Asia Pacific Committee of the AIPLA AIPPI US division, a co-chair of the International Cooperation Committee of the Korea Patent Attorney Association (KPAA), and a Korea Innovation Center (KIC) Washington DC leadership mentor. She also served as a president of the KAIPBA.